with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab. 2006 Mar; 91(3):843-50.
Laaksonen DE et al. Sex hormones, inflammation and the metabolic syndrome: a population-albased study.Eur J Endocrinol. 2003 Dec; 149(6):601-8
Laaksonen DE et al. Testosterone and Sex Hormone-Binding Globulin Predict the Metabolic Syndrome and Diabetes in Middle-Aged Men.Diabetes Care. 2004 May;27(5):1036-1041
LeBlanc ES, Wang PY, Janowsky JS, Neiss MB, Fink HA, Yaffe K, Marshall LM, Lapidus JA, Stefanick ML, Orwoll ES; Osteoporotic Fractures in Men (MrOS) Research Group. Association between sex steroids and cognition in elderly men. Clin Endocrinol (Oxf). 2010 Mar;72(3):393-403.
LeBlanc ES, Wang PY, Lee CG, et al. Higher testosterone levels are associated with less loss of lean body mass in older men. J Clin Endocrinol Metab. 2011;96:3855-3863.
Leder BZ et al. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.J Clin Endocrinol Metab. 2004 Mar; 89(3):1174-80.
Lunenfeld B Endocrinology of the aging male. Minerva Ginecol. 2006 Apr; 58(2):153-70
Maggio M et al. Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor (sIL-6r) in older men.J Clin Endocrinol Metab. 2005 Nov 1
Makinen J et al. Increased carotid atherosclerosis in andropausal middle-aged men.J Am Coll Cardiol. 2005 May 17; 45(10)
Malkin CJ et al. Testosterone as a protective factor against atherosclerosis--immunomodulation and influence upon plaque development and stability. J Endocrinol. 2003 Sep; 178(3):373-80
Malkin CJ et al. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Heart. 2004 Aug; 90(8):871-6.
Malkin CJ et al. Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial. Eur Heart J. 2005 Aug 10
Malkin CJ et al. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men J Clin Endocrinol Metab. 2004 Jul; 89(7):3313-8.
Marks LS et al. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial JAMA. 2006 Nov 15; 296(19):2369-71.
Moffat SD, Resnick SM. Long-term measures of free testosterone predict regional cerebral blood flow patterns in elderly men.Neurobiol Aging. 2006 May 11
Morales A. Monitoring androgen replacement therapy: testosterone and prostate safety.J Endocrinol Invest. 2005; 28(3 Suppl):122-7
Morales A.Androgen replacement therapy and prostate safety.Eur Urol 2002 Feb; 41(2):113-20
Morgentaler A et al. Testosterone therapy in men with untreated prostate cancer. Journal of Urology 2011 Apr;185(4)9.
Morgentaler A Testosterone and Prostate Cancer: An Historical Perspective on a Modern Myth. Eur Urol. 2006 Jul 26
Morgentaler A Testosterone replacement therapy and prostate risks: where's the beef? Can J Urol. 2006 Feb; 13 Suppl 1:40-3.
Morgentaler A. et al Two years of testosterone therapy associated with decline in prostate-specific antigen in a man with untreated prostate cancer. J Sex Med. 2009 Feb; 6(2):574-7.
Morgentaler, M. Guideline for Male Testosterone therapy. A clinician’s perspective. J. Clin Endo Metab. 92 (2) 416-417, 2007 no abstract available
Morley J. Testosterone and frailty. Clin Geriatr Med 1997 Nov;13(4):685-95
Morley JE. Testosterone replacement and the physiologic aspects of aging in men.Mayo Clin Proc. 2000 Jan; 75 Suppl: S83-7
Mudali S, Dobs AS Effects of testosterone on body composition of the aging male. Mech Ageing Dev. 2004 Apr; 125(4):297-304
Mudali S, Dobs AS. Effects of testosterone on body composition of the aging male. Mech Ageing Dev. 2004;125:297-304.
Muller M et al. Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation. 2004 May 4; 109(17):2074-9.
Muniyappa R et al. Long-Term Testosterone Supplementation Augments Overnight Growth Hormone Secretion in Healthy Older Men. Am J Physiol Endocrinol Metab. 2007
Vakkat Muraleedharan and T. Hugh Jones. “Review: Testosterone and the metabolic syndrome,” Therapeutic Advances in Endocrinology and Metabolism 2010 1: 207.
Nathan L et al. Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase. Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3589-93
Nettleship JE, Jones RD, Channer KS, Jones TH. Testosterone and coronary artery disease. Front Horm Res. 2009;37:91-107.
O'Connor DB, Archer J, Hair WM, Wu FC. Exogenous testosterone, aggression, and mood in eugonadal and hypogonadal men. Physiol Behav. 2002;75:557-566.
Oettel M et al. Progesterone: the forgotten hormone in men? Aging Male. 2004 Sep; 7(3):236-57
Padero MC et al. Androgen supplementation in older women: too much hype, not enough data. J Am Geriatr Soc 2002 Jun; 50(6):1131-40
Pantuck AJ et al. Phase II Study of Pomegranate Juice for Men with Rising Prostate-Specific Antigen following Surgery or Radiation for Prostate Cancer.Clin Cancer Res. 2006 Jul 1;12(13):4018-4026
Phillips GB Relationship between serum sex hormones and coronary artery disease in postmenopausal women. Arterioscler Thromb Vasc Biol. 1997 Apr; 17(4):695-701
Phillips GB. Is atherosclerotic cardiovascular disease an endocrinological disorder? The estrogen-androgen paradox. J Clin Endocrinol Metab. 2005 May;90(5):2708-11
Prehn RT. On the prevention and therapy of prostate cancer by androgen administration. Cancer Res 1999 Sep 1; 59(17):4161-4
Pugh PJ, Jones RD, West JN, Jones TH, Channer KS. Testosterone treatment for men with chronic heart failure. Heart. 2004 Apr;90(4):446-7.
Rao et al. Effect of testosterone on threshold of pain.Indian J Physiol Pharmacol. 1981 Oct-Dec; 25(4):387-8.
Rhoden EL, Averbeck MA. [Prostate carcinoma and testosterone: risks and controversies]. Arq Bras Endocrinol Metabol. 2009 Nov;53(8):956-62.
Rosano GM et al. Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation 1999 Apr 6; 99(13):1666-70
Sarosdy MF. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy. Cancer. 2007 Feb 1;109(3):536-41
Schmidt M et al. Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes--androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5alpha-reduced androgens. Arthritis Res Ther. 2005; 7(5):R938-48.
Schmidt M, Renner C, Loffler G. Progesterone inhibits glucocorticoid-dependent aromatase induction in human adipose fibroblasts. J Endocrinol. 1998 Sep;158(3):401-7
Schubert M et al. Intramuscular testosterone undecanoate: pharmacokinetic aspects
